Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Molecular Neurobiology

• Publication date

  2014-11-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12035-014-8952-xPMID 25367883PMCID PMC4418959
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased globulin and its association with hemorrhagic transformation in patients receiving intra-arterial thrombolysis therapy

  2014cited by this paper
• Progressive Hemorrhagic Transformation Following Dual Antiplatelet Therapy

  2014cited by this paper
• Fluid-Attenuated Inversion Recovery Hyperintensity Correlates With Matrix Metalloproteinase-9 Level and Hemorrhagic Transformation in Acute Ischemic Stroke

  2014cited by this paper
• Src regulates angiogenic factors and vascular permeability after focal cerebral ischemia-reperfusion.

  2014cited by this paper
• Trasmembrane chemokines CX3CL1 and CXCL16 drive interplay between neurons, microglia and astrocytes to counteract pMCAO and excitotoxic neuronal death

  2014cited by this paper
• Hemorrhagic Transformation after Ischemic Stroke in Animals and Humans

  2014cited by this paper
• Therapeutic Hypothermia After Recanalization in Patients With Acute Ischemic Stroke

  2014cited by this paper
• SMTP-7, a new thrombolytic agent, decreases hemorrhagic transformation after transient middle cerebral artery occlusion under warfarin anticoagulation in mice.

  2014cited by this paper
• Ischemic neurons activate astrocytes to disrupt endothelial barrier via increasing VEGF expression

  2014cited by this paper
• Triggers and Effectors of Oxidative Stress at Blood-Brain Barrier Level: Relevance for Brain Ageing and Neurodegeneration

  2013influential reference
• Adapting the Computed Tomography Criteria of Hemorrhagic Transformation to Stroke Magnetic Resonance Imaging

  2013cited by this paper
• Fingolimod Reduces Hemorrhagic Transformation Associated With Delayed Tissue Plasminogen Activator Treatment in a Mouse Thromboembolic Model

  2013cited by this paper
• Ischemia-Reperfusion Injury in Stroke

  2013cited by this paper
• Hemorrhagic transformation in acute ischemic stroke

  2013cited by this paper
• Matrix Metalloproteinases and Blood-Brain Barrier Disruption in Acute Ischemic Stroke

  2013cited by this paper
• Endovascular therapy after intravenous t-PA versus t-PA alone for stroke.

  2013cited by this paper
• MMP9 Variation After Thrombolysis Is Associated With Hemorrhagic Transformation of Lesion and Death

  2013cited by this paper
• Matrix metalloproteinase-2 deletions protect against hemorrhagic transformation after 1 h of cerebral ischemia and 23 h of reperfusion.

  2013cited by this paper
• New Appearance of Extraischemic Microbleeds on T2*-Weighted Magnetic Resonance Imaging 24 Hours After Tissue-type Plasminogen Activator Administration

  2013cited by this paper
• Multi-center prediction of hemorrhagic transformation in acute ischemic stroke using permeability imaging features.

  2013cited by this paper
• Cilostazol Ameliorates Warfarin-Induced Hemorrhagic Transformation After Cerebral Ischemia in Mice

  2013cited by this paper
• Predictors for hemorrhagic transformation with intravenous tissue plasminogen activator in acute ischemic stroke.

  2013cited by this paper
• proMetalloproteinase‐10 is associated with brain damage and clinical outcome in acute ischemic stroke

  2013cited by this paper
• A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator.

  2012cited by this paper
• A Surgical Model of Permanent and Transient Middle Cerebral Artery Stroke in the Sheep

  2012cited by this paper
• Relationship between plasma metalloproteinase-9 levels and volume and severity of infarct in patients with acute ischemic stroke

  2012cited by this paper
• Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion.

  2012cited by this paper
• Neuroprotection from tissue inhibitor of metalloproteinase-1 and its nanoparticles.

  2012cited by this paper
• Neuroprotective effect of early and short-time applying sophoridine in pMCAO rat brain: down-regulated TRAF6 and up-regulated p-ERK1/2 expression, ameliorated brain infaction and edema.

  2012cited by this paper
• Matrix metalloproteinase 9 mRNA: an early prognostic marker for patients with acute stroke.

  2012cited by this paper
• Inhibition of MMP-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia

  2012cited by this paper
• Microglial Cell Activation is a Source of Metalloproteinase Generation during Hemorrhagic Transformation

  2012cited by this paper
• Temporal profile of Src, SSeCKS, and angiogenic factors after focal cerebral ischemia: correlations with angiogenesis and cerebral edema.

  2011cited by this paper
• Inhibition of VEGF signaling pathway attenuates hemorrhage after tPA treatment

  2011cited by this paper
• Tissue inhibitor of matrix metalloproteinase-1 mediates erythropoietin-induced neuroprotection in hypoxia ischemia.

  2011cited by this paper
• Lentivirus-mediated transfer of MMP-9 shRNA provides neuroprotection following focal ischemic brain injury in rats.

  2011cited by this paper
• Matrix Metalloproteinase-9 in an Exploratory Trial of Intravenous Minocycline for Acute Ischemic Stroke

  2011cited by this paper
• Amyloid- (cid:1) Contributes to Blood–Brain Barrier Leakage in Transgenic Human Amyloid Precursor Protein Mice and in Humans With Cerebral Amyloid Angiopathy

  2011cited by this paper
• Increased Blood–Brain Barrier Permeability and Brain Edema After Focal Cerebral Ischemia Induced by Hyperlipidemia: Role of Lipid Peroxidation and Calpain-1/2, Matrix Metalloproteinase-2/9, and RhoA Overactivation

  2011cited by this paper
• A Mouse Model of Hemorrhagic Transformation by Delayed Tissue Plasminogen Activator Administration After In Situ Thromboembolic Stroke

  2011cited by this paper
• Warfarin Anticoagulation Exacerbates the Risk of Hemorrhagic Transformation after rt-PA Treatment in Experimental Stroke: Therapeutic Potential of PCC

  2011cited by this paper
• Early Ischemic Change on CT Versus Diffusion-Weighted Imaging for Patients With Stroke Receiving Intravenous Recombinant Tissue-Type Plasminogen Activator Therapy: Stroke Acute Management With Urgent Risk-factor Assessment and Improvement (SAMURAI) rt-PA Registry

  2011cited by this paper
• Microbleeds Are Associated With Subsequent Hemorrhagic and Ischemic Stroke in Healthy Elderly Individuals

  2011cited by this paper
• Increased Risk of Hemorrhagic Transformation in Ischemic Stroke Occurring During Warfarin Anticoagulation: An Experimental Study in Mice

  2011cited by this paper
• Asymptomatic Hemorrhagic Transformation of Infarction and Its Relationship With Functional Outcome and Stroke Subtype: Assessment From the Tinzaparin in Acute Ischaemic Stroke Trial

  2010cited by this paper
• Oxidative Stress Increases Blood–Brain Barrier Permeability and Induces Alterations in Occludin during Hypoxia–Reoxygenation

  2010cited by this paper
• Preclinical and clinical research on inflammation after intracerebral hemorrhage.

  2010influential reference
• Therapeutic application of gene silencing MMP‐9 in a middle cerebral artery occlusion‐induced focal ischemia rat model

  2009cited by this paper
• Disruptions of occludin and claudin‐5 in brain endothelial cells in vitro and in brains of mice with acute liver failure

  2009cited by this paper
• [Cerebral ischemia (2), How to neutralize the neurotoxic effects of tPA].

  2009cited by this paper
• Animal models of ischemic stroke.

  2009cited by this paper
• Associations of Proinflammatory Cytokines With the Risk of Recurrent Stroke

  2008cited by this paper
• MMP-9–Positive Neutrophil Infiltration Is Associated to Blood–Brain Barrier Breakdown and Basal Lamina Type IV Collagen Degradation During Hemorrhagic Transformation After Human Ischemic Stroke

  2008cited by this paper
• Extension of the Thrombolytic Time Window With Minocycline in Experimental Stroke

  2008cited by this paper
• Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies.

  2008cited by this paper
• Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

  2008cited by this paper
• Oxidative Stress and Matrix Metalloproteinase-9 in Acute Ischemic Stroke: The Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) Study

  2008cited by this paper
• Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke.

  2008cited by this paper
• Mechanisms and markers for hemorrhagic transformation after stroke.

  2008cited by this paper
• Do in vivo Experimental Models Reflect Human Cerebral Small Vessel Disease? a Systematic Review

  2008cited by this paper
• Bleeding Risk Analysis in Stroke Imaging Before ThromboLysis (BRASIL): Pooled Analysis of T2*-Weighted Magnetic Resonance Imaging Data From 570 Patients

  2007cited by this paper
• Fibronectin- and vitronectin-induced microglial activation and matrix metalloproteinase-9 expression is mediated by integrins alpha5beta1 and alphavbeta5.

  2007cited by this paper
• Fibronectin- and Vitronectin-Induced Microglial Activation and Matrix Metalloproteinase-9 Expression Is Mediated by Integrins α5β1 and αvβ51

  2007cited by this paper
• Measuring Elevated Microvascular Permeability and Predicting Hemorrhagic Transformation in Acute Ischemic Stroke Using First-Pass Dynamic Perfusion CT Imaging

  2007cited by this paper
• Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

  2007cited by this paper
• Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke.

  2007cited by this paper
• Inflammation after Intracerebral Hemorrhage

  2007cited by this paper
• Increased Brain Expression of Matrix Metalloproteinase-9 After Ischemic and Hemorrhagic Human Stroke

  2006cited by this paper
• Loss of flow induces leukocyte-mediated MMP/TIMP imbalance in dynamic in vitro blood-brain barrier model: role of pro-inflammatory cytokines.

  2006cited by this paper
• Pretreatment Hemostatic Markers of Symptomatic Intracerebral Hemorrhage in Patients Treated With Tissue Plasminogen Activator

  2006cited by this paper
• Pretreatment Hemostatic Markers of Symptomatic Intracerebral Hemorrhage in Patients Treated With Tissue Plasminogen Activator

  2006cited by this paper
• Effects of the Chemokine CCL2 on Blood–Brain Barrier Permeability during Ischemia–Reperfusion Injury

  2006cited by this paper
• Effect of neutrophil depletion on gelatinase expression, edema formation and hemorrhagic transformation after focal ischemic stroke

  2005cited by this paper
• Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage.

  2005cited by this paper
• Reperfusion-Induced Oxidative/Nitrative Injury to Neurovascular Unit After Focal Cerebral Ischemia

  2004cited by this paper
• Admission Fibrinolytic Profile Is Associated With Symptomatic Hemorrhagic Transformation in Stroke Patients Treated With Tissue Plasminogen Activator

  2004cited by this paper
• Extracellular proteolytic pathophysiology in the neurovascular unit after stroke

  2004cited by this paper
• Regulation of late-phase LTP and long-term memory in normal and aging hippocampus: role of secreted proteins tPA and BDNF.

  2004cited by this paper
• Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C

  2004cited by this paper
• tPA and proteolysis in the neurovascular unit.

  2004cited by this paper
• Cerebral Microvessel Responses to Focal Ischemia

  2003cited by this paper
• Cell Type-Specific Roles for Tissue Plasminogen Activator Released by Neurons or Microglia after Excitotoxic Injury

  2003cited by this paper
• Cerebral Microbleeds as a Risk Factor for Subsequent Intracerebral Hemorrhages Among Patients With Acute Ischemic Stroke

  2003cited by this paper
• Lipoprotein receptor–mediated induction of matrix metalloproteinase by tissue plasminogen activator

  2003cited by this paper
• Triggers and mediators of hemorrhagic transformation in cerebral ischemia

  2003cited by this paper
• Involvement of Matrix Metalloproteinase in Thrombolysis-Associated Hemorrhagic Transformation After Embolic Focal Ischemia in Rats

  2002cited by this paper
• Rapid Breakdown of Microvascular Barriers and Subsequent Hemorrhagic Transformation After Delayed Recombinant Tissue Plasminogen Activator Treatment in a Rat Embolic Stroke Model

  2002cited by this paper
• Matrix metalloproteinases in neuroinflammation

  2002cited by this paper
• Relationship between metabolic dysfunctions, gene responses and delayed cell death after mild focal cerebral ischemia in mice.

  2001cited by this paper
• Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia.

  2001cited by this paper
• The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling

  2001cited by this paper
• Evolution of Brain Infarction after Transient Focal Cerebral Ischemia in Mice

  2000cited by this paper
• Reduction of Tissue Plasminogen Activator-Induced Hemorrhage and Brain Injury by Free Radical Spin Trapping after Embolic Focal Cerebral Ischemia in Rats

  2000cited by this paper
• Intra-arterial Prourokinase for Acute Ischemic Stroke

  2000cited by this paper
• Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial

  1999cited by this paper
• Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

  1999cited by this paper
• Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group.

  1999cited by this paper
• Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial.

  1999cited by this paper
• Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease.

  1998cited by this paper
• Activation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral Ischemia

  1998cited by this paper

• Impact of Asymptomatic Intracranial Hemorrhage on Outcome After Endovascular Stroke Treatment.

  2026cites this paper
• Combined treatment with tPA and Chinese herbal medicine for ischemic stroke: is it valuable?

  2026cites this paper
• Asparagine Endopeptidase Inhibition Attenuates Tissue Plasminogen Activator‐Induced Brain Hemorrhagic Transformation After Ischemic Stroke

  2025cites this paper
• Comprehensive and high-coverage glycerophospholipidomic analysis based on iterative quadrupole time-of-flight mass spectrometry and its application in cerebral ischemia–reperfusion injury

  2025cites this paper
• Regulation of Blood–Brain Barrier Permeability via JNK Signaling Pathway: Mechanisms and Potential Therapeutic Strategies for Ischemic Stroke, Alzheimer’s Disease and Brain Tumors

  2025cites this paper
• Matrix metalloproteinase-9 in hemorrhagic transformation after acute ischemic stroke (Review)

  2025cites this paper
• Genetic Polymorphisms of Apolipoprotein E and Their Impact on Ischemic Stroke Severity and Recovery

  2025cites this paper
• ENDOTHELIAL GLYCOCALYX DEGRADATION IN CEREBRAL EDEMA: PROMISING OPPORTUNITIES FOR INTENSIVE CARE

  2025cites this paper
• Acupuncture Alleviates Blood–Brain Barrier Damage After Delayed rtPA Thrombolysis for Acute Ischemic Stroke by Regulating Ferroptosis

  2025cites this paper
• The role of ASPECTS score, atrial fibrillation, and revascularization therapy in predicting hemorrhagic transformation of ischemic stroke: results from a prospective cohort study

  2025cites this paper
• High-Resolution Spatiotemporal Mapping of Cerebral Metabolism During Middle-Cerebral-Artery Occlusion/Reperfusion Progression: Preliminary Insights

  2025cites this paper
• Mild Hypothermia After Endovascular Treatment for Acute Ischemic Stroke: A Pilot Randomized Controlled Trial.

  2025cites this paper
• Predictive value of the fibrinogen-to-albumin ratio for hemorrhagic transformation following intravenous thrombolysis in ischemic stroke: a retrospective propensity score-matched analysis

  2025cites this paper
• Alpha‑Asarone Ameliorates Neuronal Injury After Ischemic Stroke and Hemorrhagic Transformation by Attenuating Blood–Brain Barrier Destruction, Promoting Neurogenesis, and Inhibiting Neuroinflammation

  2024cites this paper
• Investigating Neutrophil-to-Lymphocyte Ratio and Risk Factors for Hemorrhagic Transformation Following Thrombolytic Therapy: Insights from a Cross-Sectional Study

  2024cites this paper
• Enhancing Blood–Brain Barrier Integrity in Patients With Acute Ischemic Stroke Via Normobaric Hyperoxia

  2024cites this paper
• Dexmedetomidine promotes the functional recovery of mice after acute ischemic stroke via activation of the α2-adrenoceptor.

  2024cites this paper
• Study on the Correlation between Serum Uric Acid Level and Hemorrhagic Transformation after Intravenous Thrombolysis in Acute Ischemic Stroke

  2024cites this paper
• Nattokinase’s Neuroprotective Mechanisms in Ischemic Stroke: Targeting Inflammation, Oxidative Stress, and Coagulation

  2024cites this paper
• Dexmedetomidine alleviates blood-brain barrier disruption in rats after cerebral ischemia-reperfusion by suppressing JNK and p38 MAPK signaling.

  2024cites this paper
• Innovations in Breaking Barriers: Liposomes as Near-Perfect Drug Carriers in Ischemic Stroke Therapy

  2024cites this paper
• The combination model of serum occludin and clinical risk factors improved the efficacy for predicting hemorrhagic transformation in stroke patients with recanalization

  2024cites this paper
• Prediction factors and clinical significance of different types of hemorrhagic transformation after intravenous thrombolysis

  2023cites this paper
• The role of neuro-inflammatory in the pathogenesis of brain edema and hemorrhagic transformation in ischemic stroke: mechanisms and therapeutic target

  2023cites this paper
• The early predictive value of platelet-to-lymphocyte ratio to hemorrhagic transformation of young acute ischemic stroke

  2023cites this paper
• Hemorrhagic Coagulation Disorders and Ischemic Stroke: How to Reconcile Both?

  2023cites this paper
• Therapeutic management of ischemic stroke

  2023cites this paper
• Carbon Dots -A Turn-On Probe for Neurological Disorder

  2023cites this paper
• Prevalence, Risk Factors, and Clinical Outcomes of New Cerebral Microbleeds After Intravenous Thrombolysis in Acute Ischemic Stroke: a Systematic Review and Meta-analysis

  2023cites this paper
• The role of red blood cell distribution width to platelet ratio in predicting hemorrhagic transformation after mechanical thrombectomy therapy in acute ischemic stroke patients

  2023cites this paper
• The Recent Applications of PLGA-Based Nanostructures for Ischemic Stroke

  2023cites this paper
• Emerging nanotechnological approaches to regulating tumor vasculature for cancer therapy.

  2023cites this paper
• LOX-1 and MMP-9 inhibition attenuates the detrimental effects of delayed rt-PA therapy and improves outcomes after acute ischemic stroke

  2023cites this paper
• The Association between Increased Serum Level of Matrix Metalloproteinase 9 and the Risk of Acute Ischemic Stroke

  2023cites this paper
• A modified mouse model of haemorrhagic transformation associated with tPA administration after thromboembolic stroke

  2023cites this paper
• Animal toxins: As an alternative therapeutic target following ischemic stroke condition.

  2023cites this paper
• Emergency admission plasma D-dimer: a novel predictor for symptomatic intracranial hemorrhage after thrombectomy in acute ischemic stroke

  2023cites this paper
• Targeted thrombolysis by magnetoacoustic particles in photothrombotic stroke model

  2022cites this paper
• Profiling the neurovascular unit unveils detrimental effects of osteopontin on the blood–brain barrier in acute ischemic stroke

  2022cites this paper
• Change of Serum Biomarkers to Post-Thrombolytic Symptomatic Intracranial Hemorrhage in Stroke

  2022cites this paper
• Combination of puerarin and tanshinone IIA alleviates ischaemic stroke injury in rats via activating the Nrf2/ARE signalling pathway

  2022cites this paper
• COMPREHENSIVE STUDY OF MANIFESTATIONS OF BRAIN TISSUE RESOLUTION IN CASE OF VARIOUS TYPES OF STROKE.

  2022cites this paper
• DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval versus Standard Bridging Therapy

  2022cites this paper
• Association of Serum Biomarkers With Post-Thrombolytic Symptomatic Intracranial Hemorrhage in Stroke: A Comprehensive Protein Microarray Analysis From INTRECIS Study

  2022cites this paper
• Association between malnutrition risk and hemorrhagic transformation in patients with acute ischemic stroke

  2022cites this paper
• Hyponatremia Is Associated With Post-thrombolysis Hemorrhagic Transformation and Poor Clinical Outcome in Ischemic Stroke Patients

  2022cites this paper
• Prognostic Value of a New Integrated Parameter—Both Collateral Circulation and Permeability Surface—in Hemorrhagic Transformation of Middle Cerebral Artery Occlusion Acute Ischemic Stroke: Retrospective Cohort Study

  2021cites this paper
• Role of NADPH Oxidase-Induced Hypoxia-Induced Factor-1α Increase in Blood-Brain Barrier Disruption after 2-Hour Focal Ischemic Stroke in Rat

  2021cites this paper
• Paradoxical role of hepatocyte growth factor in ischemic stroke: stroke risk/stroke recovery

  2021cites this paper
• Selenium attenuates ischemia/reperfusion injury-induced damage to the blood-brain barrier in hyperglycemia through PI3K/AKT/mTOR pathway-mediated autophagy inhibition

  2021cites this paper
• Insight into Crosstalk between Ferroptosis and Necroptosis: Novel Therapeutics in Ischemic Stroke

  2021cites this paper
• Disrupted Blood‐Brain Barrier and Mitochondrial Impairment by Autotaxin–Lysophosphatidic Acid Axis in Postischemic Stroke

  2021cites this paper
• Differences in the Prevention and Control of Cardiovascular and Cerebrovascular Diseases.

  2021cites this paper
• Blood-brain barrier dysfunction in hemorrhagic transformation: a therapeutic opportunity for nanoparticles and melatonin.

  2021cites this paper
• Pinocembrin attenuates hemorrhagic transformation after delayed t-PA treatment in thromboembolic stroke rats by regulating endogenous metabolites

  2021cites this paper
• Inhibition of hypoxia inducible factor 1 by YC-1 attenuates tissue plasminogen activator induced hemorrhagic transformation by suppressing HMGB1/TLR4/NF-κB mediated neutrophil infiltration in thromboembolic stroke rats.

  2021cites this paper
• Silver Jubilee of Stroke Thrombolysis With Alteplase: Evolution of the Therapeutic Window

  2021cites this paper
• Effects of ML351 and tissue plasminogen activator combination therapy in a rat model of focal embolic stroke

  2021cites this paper
• SWATH-MS for prospective identification of protein blood biomarkers of rtPA-associated intracranial hemorrhage in acute ischemic stroke: a pilot study

  2021cites this paper
• Neurovascular Unit: A critical role in ischemic stroke

  2021cites this paper
• Thrombolytic Therapy: tPA-Induced Bleeding

  2021cites this paper
• Difficult questions of intravenous thrombolytic therapy in ischemic stroke

  2021cites this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Desmoteplase

  2021cites this paper
• Study on the Baseline Factors and Platelet Indices That Predict Outcome of Acute Ischemic Stroke Patients after Thrombolytic Therapy

  2021cites this paper
• Non-negligible clinical relevance of haemorrhagic transformation after endovascular thrombectomy with successful reperfusion in acute ischaemic stroke.

  2021cites this paper
• Hemorrhagic transformation after acute ischemic stroke caused by polycythemia vera: Report of two case

  2021cites this paper
• Fibrinogen Level Combined With Platelet Count for Predicting Hemorrhagic Transformation in Acute Ischemic Stroke Patients Treated With Mechanical Thrombectomy

  2021cites this paper
• High red blood cell distribution width levels could increase the risk of hemorrhagic transformation after intravenous thrombolysis in acute ischemic stroke patients

  2021cites this paper
• Diabetes mellitus: A common comorbidity increasing hemorrhagic transformation after tPA thrombolytic therapy for ischemic stroke

  2020cites this paper
• Protein-Carbon Dot Nanohybrid-Based Early Blood-Brain Barrier Damage Theranostics.

  2020cites this paper
• Salvianolic Acid D Alleviates Cerebral Ischemia-Reperfusion Injury by Suppressing the Cytoplasmic Translocation and Release of HMGB1-Triggered NF-κB Activation to Inhibit Inflammatory Response

  2020cites this paper
• Carbon dots as versatile nanoarchitectures for the treatment of neurological disorders and their theranostic applications: A review.

  2020cites this paper
• Neutrophil to Lymphocyte Ratio Is a Therapeutic Biomarker for Spontaneous Hemorrhagic Transformation

  2020cites this paper
• Serum Occludin as a Biomarker to Predict the Severity of Acute Ischemic Stroke, Hemorrhagic Transformation, and Patient Prognosis

  2020cites this paper
• Icariside II attenuates cerebral ischemia/reperfusion-induced blood–brain barrier dysfunction in rats via regulating the balance of MMP9/TIMP1

  2020cites this paper
• Association of plasma level of growth differentiation factor-15 and clinical outcome after intraarterial thrombectomy.

  2020cites this paper
• Comparison of the risk factors of hemorrhagic transformation between large artery atherosclerosis stroke and cardioembolism after intravenous thrombolysis.

  2020cites this paper
• D1 receptor‐mediated endogenous tPA upregulation contributes to blood‐brain barrier injury after acute ischaemic stroke

  2020cites this paper
• Low Serum Magnesium Levels Are Associated With Hemorrhagic Transformation After Thrombolysis in Acute Ischemic Stroke

  2020cites this paper
• Liver Fibrosis Is Associated With Hemorrhagic Transformation in Patients With Acute Ischemic Stroke

  2020cites this paper
• Interferon-β alleviates delayed tPA-induced adverse effects via modulation of MMP3/9 production in ischemic stroke.

  2020cites this paper
• Occludin regulation of blood–brain barrier and potential therapeutic target in ischemic stroke

  2020cites this paper
• Screening of serum protein biomarkers in hemorrhagic cerebral infarction by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) technology

  2020cites this paper
• Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment in Acute Ischemic Stroke

  2020cites this paper
• Association Between Plasma Total Homocysteine Levels and Risk of Early Hemorrhagic Transformation in Patients with Acute Ischemic Stroke: A Hospital-Based Study.

  2020cites this paper
• Liver Fibrosis Indices and Hemorrhagic Transformation After Ischemic Stroke

  2020influential citation
• Serum Rheumatoid Factor Levels at Acute Phase of Ischemic Stroke are Associated with Poststroke Cognitive Impairment.

  2019cites this paper
• Poly-arginine-18 peptides do not exacerbate bleeding, or improve functional outcomes following collagenase-induced intracerebral hemorrhage in the rat

  2019cites this paper
• Wnt-3a alleviates neuroinflammation after ischemic stroke by modulating the responses of microglia/macrophages and astrocytes.

  2019cites this paper
• Multiple biomarkers covering several pathways improve predictive ability for cognitive impairment among ischemic stroke patients with elevated blood pressure.

  2019cites this paper
• Rosiglitazone ameliorates tissue plasminogen activator‐induced brain hemorrhage after stroke

  2019cites this paper
• Neutrophils in tPA‐induced hemorrhagic transformations: Main culprit, accomplice or innocent bystander?

  2019cites this paper
• tPA Helpers in the Treatment of Acute Ischemic Stroke: Are They Ready for Clinical Use?

  2019cites this paper
• Hippo/YAP signaling pathway mitigates blood‐brain barrier disruption after cerebral ischemia/reperfusion injury

  2019cites this paper
• Potential roles of matricellular proteins in stroke.

  2019cites this paper
• Cathepsin K Knockout Exacerbates Haemorrhagic Transformation Induced by Recombinant Tissue Plasminogen Activator After Focal Cerebral Ischaemia in Mice

  2019cites this paper
• Ultrasound Identification of Patients at Increased Risk of Intracranial Hemorrhage After Successful Endovascular Recanalization for Acute Ischemic Stroke.

  2019cites this paper
• The Risk of Symptomatic Intracranial Hemorrhage after Thrombolysis for Acute Stroke: Current Concepts and Perspectives

  2019cites this paper
• Rosuvastatin Reduces Neuroinflammation in the Hemorrhagic Transformation After rt-PA Treatment in a Mouse Model of Experimental Stroke

  2018influential citation
• Astaxanthin mitigates subarachnoid hemorrhage injury primarily by increasing sirtuin 1 and inhibiting the Toll‐like receptor 4 signaling pathway

  2018cites this paper